JPY7,321.00
0.26% today
Tokyo, Aug 04, 04:15 am CET
ISIN
JP3519400000
Symbol
4519
Index

Chugai Pharmaceutical Stock price

JPY7,340.00
+103.00 1.42% 1M
+706.27 10.65% 6M
+410.22 5.92% YTD
+924.09 14.40% 1Y
+3,581.54 95.29% 3Y
+2,485.49 51.20% 5Y
+5,837.11 388.39% 10Y
+6,707.52 1,060.51% 20Y
Tokyo, Closing price Fri, Aug 01 2025
-20.00 0.27%
ISIN
JP3519400000
Symbol
4519
Index
Industry

Key metrics

Basic
Market capitalization
JPY12.1t
Enterprise Value
-
Net debt
-
Cash
-
Shares outstanding
-
Valuation (TTM | estimate)
P/E
30.5 | 28.1
P/S
10.1 | 9.8
EV/Sales
- | -
EV/FCF
-
P/B
-
Dividends
DPS
JPY250.00
Yield 1Y | 5Y
1.4% | 1.8%
Growth 1Y | 5Y
3.1% | 12.9%
Payout 1Y | 3Y
41.2% | 38.4%
Increased
13 Years
Financials (TTM | estimate)
Revenue
JPY1.2t | JPY1.2t
EBITDA
- | JPY627.6b
EBIT
JPY557.1b | -
Net Income
JPY395.4b | -
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
10.3% | 5.7%
EBITDA
- | 14.4%
EBIT
14.5% | -
Net Income
11.4% | -
Free Cash Flow
-
Margin (TTM | estimate)
Gross
70.4%
EBITDA
- | 50.7%
EBIT
46.6%
Net
33.1% | -
Free Cash Flow
-
Financial Health
Equity Ratio
86.1%
Return on Equity
20.4%
ROCE
-
ROIC
-
Debt/Equity
-
More
EPS
JPY240.3
FCF per Share
-
Short interest
-
Employees
5k
Rev per Employee
JPY232.9m
Show more

Is Chugai Pharmaceutical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,029 stocks worldwide.

Chugai Pharmaceutical Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Chugai Pharmaceutical forecast:

12x Buy
60%
8x Hold
40%

Analyst Opinions

20 Analysts have issued a Chugai Pharmaceutical forecast:

Buy
60%
Hold
40%

Financial data from Chugai Pharmaceutical

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
1,196,214 1,196,214
10% 10%
100%
- Direct Costs 354,410 354,410
7% 7%
30%
841,804 841,804
12% 12%
70%
- Selling and Administrative Expenses 111,845 111,845
3% 3%
9%
- Research and Development Expense 183,739 183,739
7% 7%
15%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 557,149 557,149
14% 14%
47%
Net Profit 395,444 395,444
11% 11%
33%

In millions JPY.

Don't miss a Thing! We will send you all news about Chugai Pharmaceutical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of the pharmaceuticals. Its operations are carried out through the following business divisions: Research, Development, Production, Marketing, Medical Affairs and Drug Safety. The Research division focuses its efforts on creating innovative drugs by using its competitive strengths that include proprietary antibody technologies and cutting-edge research resources. The Development division provides cross-functional lifecycle management system to deliver innovative medicines to patients as quickly as possible. The Production division provides a world-class safety and quality management systems. The Marketing division conducts patient-oriented marketing activities to help solve issues related to healthcare. The Medical Affairs division works to properly deliver the value of medicines based on global compliance standards. The Drug Safety provides safety management system includes expert safety evaluation as well as timely gathering and reporting of safety information. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

Head office Japan
CEO Osamu Okuda
Employees 5,026
Founded 1925
Website www.chugai-pharm.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today